94 related articles for article (PubMed ID: 3346819)
1. Mechanisms of corneal drug penetration. III: Modeling of molecular transport.
Grass GM; Cooper ER; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):24-6. PubMed ID: 3346819
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
Grass GM; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):3-14. PubMed ID: 3126290
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement.
Grass GM; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):15-23. PubMed ID: 3346818
[TBL] [Abstract][Full Text] [Related]
4. Effects of four penetration enhancers on corneal permeability of drugs in vitro.
Tang-Liu DD; Richman JB; Weinkam RJ; Takruri H
J Pharm Sci; 1994 Jan; 83(1):85-90. PubMed ID: 8138917
[TBL] [Abstract][Full Text] [Related]
5. Computational modeling of drug transport across the in vitro cornea.
Pak J; Chen ZJ; Sun K; Przekwas A; Walenga R; Fan J
Comput Biol Med; 2018 Jan; 92():139-146. PubMed ID: 29175100
[TBL] [Abstract][Full Text] [Related]
6. Ocular membrane permeability of hydrophilic drugs for ocular peptide delivery.
Sasaki H; Ichikawa M; Yamamura K; Nishida K; Nakamura J
J Pharm Pharmacol; 1997 Feb; 49(2):135-9. PubMed ID: 9055183
[TBL] [Abstract][Full Text] [Related]
7. Effects of Tween 80 and liposomes on the corneal permeability of anti-inflammatory steroids.
Taniguchi K; Itakura K; Morisaki K; Hayashi S
J Pharmacobiodyn; 1988 Oct; 11(10):685-93. PubMed ID: 3221301
[TBL] [Abstract][Full Text] [Related]
8. A corneal perfusion device for estimating ocular bioavailability in vitro.
Richman JB; Tang-Liu DD
J Pharm Sci; 1990 Feb; 79(2):153-7. PubMed ID: 2324964
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in-vitro.
Morimoto K; Nakai T; Morisaka K
J Pharm Pharmacol; 1987 Feb; 39(2):124-6. PubMed ID: 2435884
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of transcorneal permeation of pilocarpine.
Mitra AK; Mikkelson TJ
J Pharm Sci; 1988 Sep; 77(9):771-5. PubMed ID: 3225772
[TBL] [Abstract][Full Text] [Related]
11. A simple model for the prediction of corneal permeability.
Fu XC; Liang WQ
Int J Pharm; 2002 Jan; 232(1-2):193-7. PubMed ID: 11790503
[TBL] [Abstract][Full Text] [Related]
12. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
Tirucherai GS; Dias C; Mitra AK
J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
[TBL] [Abstract][Full Text] [Related]
13. Topical carbonic anhydrase inhibitors. III: Optimization model for corneal penetration of ethoxzolamide analogues.
Eller MG; Schoenwald RD; Dixson JA; Segarra T; Barfknecht CF
J Pharm Sci; 1985 Feb; 74(2):155-60. PubMed ID: 3989684
[TBL] [Abstract][Full Text] [Related]
14. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes.
Chien DS; Homsy JJ; Gluchowski C; Tang-Liu DD
Curr Eye Res; 1990 Nov; 9(11):1051-9. PubMed ID: 1982760
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of permeability-enhancing effect of EDTA and boric acid on the corneal penetration of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088).
Kikuchi T; Suzuki M; Kusai A; Iseki K; Sasaki H; Nakashima K
Int J Pharm; 2005 Aug; 299(1-2):107-14. PubMed ID: 15979832
[TBL] [Abstract][Full Text] [Related]
16. Model of transient drug diffusion across cornea.
Zhang W; Prausnitz MR; Edwards A
J Control Release; 2004 Sep; 99(2):241-58. PubMed ID: 15380634
[TBL] [Abstract][Full Text] [Related]
17. Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes.
Gao XC; Qi HP; Bai JH; Huang L; Cui H
Curr Eye Res; 2014 Dec; 39(12):1161-8. PubMed ID: 24749683
[TBL] [Abstract][Full Text] [Related]
18. Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N-[[4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines.
Kompella UB; Sunkara G; Thomas E; Clark CR; Deruiter J
J Pharm Pharmacol; 1999 Aug; 51(8):921-7. PubMed ID: 10504031
[TBL] [Abstract][Full Text] [Related]
19. Penetration into the anterior chamber via the conjunctival/scleral pathway.
Schoenwald RD; Deshpande GS; Rethwisch DG; Barfknecht CF
J Ocul Pharmacol Ther; 1997 Feb; 13(1):41-59. PubMed ID: 9029439
[TBL] [Abstract][Full Text] [Related]
20. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
Afouna MI; Khedr A; Abdel-Naim AB; Al-Marzoqi A
J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
